Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 390 participants.
Also called NCT06115070
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 390 participants
- Registry
-
NCT06115070
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06115070. Randomized; single masking; primary purpose treatment. Start 2025-03-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
- Acronym
- ALLOW
- Condition
- Thrombosis
- Condition
- Acute Ischemic Stroke (AIS)
- Intervention (Drug)
- Intravenous thrombolysis (alteplase and other guideline-recommended thrombolytic agents)
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct06115070- Content hash
745e807fc77be433cc071ad46d58098be8c3be91963ab085f92cd2d22ab2ae0a